Next-generation sequencing diagnostics are already being used, and patients are ready.
The Scientist
Most Recent
Disgruntled Nobel loser sues; brain trauma researchers search for biomarker of a chronic condition; receptor for novel coronavirus found; the rise of transcriptomics; and ethical oversight of participant-led research
Researchers identify the target protein of a recently discovered human coronavirus, shedding light on infection and possible interspecies spread.
Research nears a biomarker for the contact-sport-associated disease that affects athletes long after they’ve retired.
Tailoring ethical oversight to participant-led research
Transcriptome studies reveal new insights about unusual animals whose genomes have not been sequenced.
A red alga appears to have adapted to extremely hot, acidic environments by collecting genes from bacteria and archaea.
Normal proteins with regions resembling disease-causing prions are responsible for an inherited disorder that affects the brain, muscle, and bone.
Although fully organized patient-run trials are still few and far between, patients are taking a more active role in clinical research.
Patients are sidestepping clinical research and using themselves as guinea pigs to test new treatments for fatal diseases. Will they hurt themselves, or science?
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
